NCT06250296 Evaluation of a New Recovery-oriented Model of Psychiatric Inpatient Care
| NCT ID | NCT06250296 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Geneva |
| Condition | Psychiatric Hospitalization |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2024-02-15 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2024-02-15 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will study the effects of a major reorganization of psychiatric inpatient wards. This reorganization will affect many aspects of day-to-day work, with the aim of improving the individualization of care, the integration of relatives and the participation of the patients in treatment planning. This new organization will initially involve a first pilot ward, before being extended to other wards. The aim of this project is to understand whether this new organization has positive effects on the use of coercive measures, the average length of stay, the improvement in patients' clinical condition, as well as on patient satisfaction, their perception of coercion, the wards' atmosphere on the unit and patients' personal recovery. All patients admitted to three wards of the Division of adult psychiatry of the Geneva University Hospital aged 18 and over, with a good knowledge of French and being treated for any type of diagnosis except dementia, are invited to take part in the study. They will be assessed at discharge regarding the selected outcomes. The study will last 18 months: during the first 9 months, the new model will be applied on the pilot ward, and the wo other wards will serve as comparison wards. After 9 months, the model will also be applied to these other two wards.
Eligibility Criteria
Inclusion Criteria: * Patients hospitalized in one of the three participating wards Exclusion Criteria: * Incapacity to give informed consent * Insufficient knowledge of French
Contact & Investigator
Alexandre Wullschleger, MD
PRINCIPAL INVESTIGATOR
University Hospital, Geneva
Frequently Asked Questions
Who can join the NCT06250296 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Psychiatric Hospitalization. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06250296 currently recruiting?
Yes, NCT06250296 is actively recruiting participants. Contact the research team at alexandre.wullschleger@hcuge.ch for enrollment information.
Where is the NCT06250296 trial being conducted?
This trial is being conducted at Thônex, Switzerland.
Who is sponsoring the NCT06250296 clinical trial?
NCT06250296 is sponsored by University Hospital, Geneva. The principal investigator is Alexandre Wullschleger, MD at University Hospital, Geneva. The trial plans to enroll 700 participants.